NCT07236242

Brief Summary

The goal of this clinical trial is to determine whether a fennel-water infusion taken by mothers reduces colic in breastfed infants. The study will also assess the effect of the fennel infusion on the mothers' milk and the gut microbiota of the infants. The main questions it aims to answer are:

  • Does a fennel-water infusion taken by mothers reduce colic in breastfed infants?
  • What changes occur in the gut microbiota of responders (participants whose infants show reduced colic symptoms after the intervention)? Researchers will evaluate changes in the microbiota of breast milk and the stool of breastfed infants after the mothers consume a fennel infusion. Participants-mothers of infants-will:
  • Take 1 L of fennel infusion daily for 7 days.
  • Keep a diary of infant colic symptoms, including time spent crying, and periods of fussiness or irritability without a definite explanation.
  • Provide breast milk and infant stool samples before treatment (day 0) and at the end of treatment (day 7) for analysis of microbial communities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 19, 2025

Completed
Last Updated

November 19, 2025

Status Verified

September 1, 2025

Enrollment Period

2.7 years

First QC Date

September 26, 2025

Last Update Submit

November 15, 2025

Conditions

Keywords

Fennel

Outcome Measures

Primary Outcomes (2)

  • Proportion of participants with a ≥50% reduction in daily crying duration as measured by a parent-reported 24-hour diary.

    Response is defined as a reduction of at least 50% from baseline in mean daily crying duration. The baseline value is the mean daily crying duration recorded by parents in a 24-hour diary for the two days before treatment initiation, as reported in a questionnaire. The post-treatment value is the mean daily crying duration recorded in the 24-hour diary on the final two days of the one-week treatment period.

    One week

  • Changes in bacterial community of infant stool samples

    The bacterial community, assessed by changes in biodiversity indices and the relative proportions of bacterial genera in infant stool samples, will be evaluated before the intervention (day 0) and at the end of the trial (day 7).

    One week

Secondary Outcomes (1)

  • Changes in bacterial community of breast milk

    One week

Study Arms (1)

Mother - Infant

EXPERIMENTAL

Breastfeeding women and their infants

Dietary Supplement: Fennel infusion

Interventions

Fennel infusionDIETARY_SUPPLEMENT

The mothers were asked to drink an infusion of fennel seeds (1 L per day) for one week .

Mother - Infant

Eligibility Criteria

Age1 Month - 5 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Breastfed infants aged 1 to 5 months, full-term (gestational age between 38 and 42 weeks) of both sexes, diagnosed with infantile colic. The ROME IV criteria for diagnosed infant colic were used in this study.

You may not qualify if:

  • Infants fed with artificial infant formula, use of antibiotics in the last 3 months by mothers or infants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidade dos Açores, IITAA

Angra do Heroísmo, Azores, 9700-042, Portugal

Location

Universidade dos Açores, FCAA

Angra do Heroísmo, Portugal

Location

MeSH Terms

Conditions

Colic

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Célia C. Silva

    IITAA, Universidade dos Açores

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Single Group Assignment
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 26, 2025

First Posted

November 19, 2025

Study Start

September 1, 2021

Primary Completion

April 30, 2024

Study Completion

December 31, 2024

Last Updated

November 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

IPD used in the results publication.

Locations